Literature DB >> 21905618

[Oropharyngeal mucositis--pain management].

S Vokurka1.   

Abstract

Oropharyngeal mucositis is a clinically significant and painful complication of an intensive chemotherapy or head and neck radiotherapy. The management of a patient in risk of this complication must include appropriate and generally recommended prophylactic measures. An effective and safe treatment must be offered to patients who have developed oropharyngeal mucositis. The basic care involves local mouthwashes, sprays or viscous gels with variable effect on pain reduction. In more serious cases, tramadol and morphine are the drugs of choice; transdermal fentanyl or buprenorphine can be considered as an alternative. Pain management must be individualized.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21905618

Source DB:  PubMed          Journal:  Klin Onkol        ISSN: 0862-495X


  2 in total

1.  Effect of Hippophae rhamnoides Extract on Oxidative Oropharyngeal Mucosal Damage Induced in Rats Using Methotrexate.

Authors:  Ertugrul Erhan; Suat Terzi; Metin Celiker; Oguzhan Yarali; Murat Cankaya; Ferda Keskin Cimen; Ismail Malkoc; Bahadir Suleyman
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-08-10       Impact factor: 3.372

2.  Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation-a phase 3 study.

Authors:  Amit Joshi; Vijay Maruti Patil; Vanita Noronha; Atanu Bhattacharjee; Nandini Menon; Amit Kumar; Parmanand Jain; Sadaf Mukadam; Avadhoot Shrinivas; Anjali Punia; Anuja Abhyankar; Amit Agarwal; Satvik Khaddar; Anu Rajpurohit; Kanteti Aditya Pavan Kumar; Rahul Ravind; Kishore Das; Vikas Talreja; Sachin Dhumal; Kumar Prabhash
Journal:  Ecancermedicalscience       Date:  2021-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.